EP0929218A4 - R2y rezeptor antagonisten - Google Patents

R2y rezeptor antagonisten

Info

Publication number
EP0929218A4
EP0929218A4 EP97952172A EP97952172A EP0929218A4 EP 0929218 A4 EP0929218 A4 EP 0929218A4 EP 97952172 A EP97952172 A EP 97952172A EP 97952172 A EP97952172 A EP 97952172A EP 0929218 A4 EP0929218 A4 EP 0929218A4
Authority
EP
European Patent Office
Prior art keywords
receptor antagonists
antagonists
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97952172A
Other languages
English (en)
French (fr)
Other versions
EP0929218A2 (de
Inventor
Jose L Boyer
T Kendall Harden
Kenneth A Jacobson
Emidio Camaioni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of North Carolina at Chapel Hill
Original Assignee
University of North Carolina at Chapel Hill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of North Carolina at Chapel Hill filed Critical University of North Carolina at Chapel Hill
Publication of EP0929218A2 publication Critical patent/EP0929218A2/de
Publication of EP0929218A4 publication Critical patent/EP0929218A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
EP97952172A 1996-10-30 1997-10-23 R2y rezeptor antagonisten Withdrawn EP0929218A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2985596P 1996-10-30 1996-10-30
US29855P 1996-10-30
PCT/US1997/019922 WO1998018430A2 (en) 1996-10-30 1997-10-23 P2y receptor antagonists

Publications (2)

Publication Number Publication Date
EP0929218A2 EP0929218A2 (de) 1999-07-21
EP0929218A4 true EP0929218A4 (de) 2001-05-16

Family

ID=21851254

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97952172A Withdrawn EP0929218A4 (de) 1996-10-30 1997-10-23 R2y rezeptor antagonisten

Country Status (5)

Country Link
EP (1) EP0929218A4 (de)
JP (1) JP2001504097A (de)
AU (1) AU5584698A (de)
CA (1) CA2241687A1 (de)
WO (1) WO1998018430A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100719606B1 (ko) 1998-02-25 2007-05-17 에모리 유니버시티 2'-플루오로뉴클레오사이드
SE9802574D0 (sv) * 1998-07-17 1998-07-17 Astra Pharma Prod Novel compounds
AU6234000A (en) * 1999-07-22 2001-02-13 Supergen, Inc. Methods for treating autoimmune diseases
US7115585B2 (en) * 2000-08-21 2006-10-03 Inspire Pharmaceuticals, Inc. Compositions for treating epithelial and retinal tissue diseases
US20040122223A1 (en) * 2001-02-07 2004-06-24 Davis Jeremy Martin Non-natural nucleotides and dinucleotides
KR20050043761A (ko) * 2001-11-06 2005-05-11 인스파이어 파마슈티컬스 인코퍼레이티드 염증성 질환의 치료 또는 예방 방법
KR20050097971A (ko) * 2003-02-03 2005-10-10 씨브이 쎄러퓨틱스, 인코포레이티드 Ａ₁아데노신 수용체의 부분 및 전 작용제
ATE460402T1 (de) 2004-05-12 2010-03-15 Bristol Myers Squibb Co Für die behandlung von thrombotischen leiden geeignete harnstoffantagonisten des p2y1- rezeptors
US7550499B2 (en) * 2004-05-12 2009-06-23 Bristol-Myers Squibb Company Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
EP1954696B1 (de) 2005-01-19 2011-02-23 Bristol-Myers Squibb Company 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-aminderivate und verwandte verbindungen als p2y1-rezeptor-hemmer zur behandlung thromboembolischer erkrankungen
AR056867A1 (es) * 2005-06-27 2007-10-31 Bristol Myers Squibb Co Antagonistas heterociclicos n- enlazados del receptor de p2y1 utiles en el tratamiento de condiciones tromboticas. composiciones farmaceuticas.
WO2007002634A1 (en) 2005-06-27 2007-01-04 Bristol-Myers Squibb Company Carbocycle and heterocycle antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
DE602006020871D1 (de) 2005-06-27 2011-05-05 Bristol Myers Squibb Co Lineare harnstoffmimetika-antagonisten des p2y1-rezeptors zur behandlung von thromboseleiden
EP1899299B1 (de) 2005-06-27 2010-10-20 Bristol-Myers Squibb Company C-verknüpfte zyklische antagonisten des p2y1-rezeptors mit eignung bei der behandlung thrombotischer leiden
US7960569B2 (en) 2006-10-17 2011-06-14 Bristol-Myers Squibb Company Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
AR064245A1 (es) 2006-11-17 2009-03-25 Epix Delaware Inc Analogos de adenosina y su uso

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2331223A1 (de) * 1972-06-19 1974-01-17 Kohjin Co S-substituierte-2-thioadenosine
US3846402A (en) * 1971-05-06 1974-11-05 Max Planck Gesellschaft Thiophosphate analogues of the nucleoside diphosphates and triphosphates and a method for the preparation thereof
GB1433507A (en) * 1972-05-15 1976-04-28 Takeda Chemical Industries Ltd Pharmaceutically active 2-substituted adenosine-3,5-cyclic monophosphates
US4266048A (en) * 1977-10-11 1981-05-05 The United States Of America As Represented By The Department Of Health, Education And Welfare Synthesis of analogs of 3'-phosphoadenosine 5'-phosphosulfate (PAPS)
US4719295A (en) * 1985-12-31 1988-01-12 Warner-Lambert Company Compound 2-iodo-2'-deoxyadenosine
US4828979A (en) * 1984-11-08 1989-05-09 Life Technologies, Inc. Nucleotide analogs for nucleic acid labeling and detection
WO1992017488A1 (en) * 1991-04-06 1992-10-15 Fisons Plc Atp analogues
WO1994018216A1 (en) * 1993-02-10 1994-08-18 Astra Pharmaceuticals Limited N-alkyl-2-substituted atp analogues
WO1995010287A1 (en) * 1993-10-15 1995-04-20 Wisconsin Alumni Research Foundation Substituted purine nucleoside analogs and method for treating endotoxin shock
WO1996029345A1 (en) * 1995-03-23 1996-09-26 The Trustees Of The University Of Pennsylvania Novel inotropic agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4788181A (en) * 1986-09-29 1988-11-29 The United States Of America As Represented By The Department Of Health And Human Services 5-substituted-2',3'-dideoxycytidine compounds with anti-HTLV-III activity
US5620676A (en) * 1994-03-08 1997-04-15 The United States Of America As Represented By The Department Of Health And Human Services Biologically active ATP analogs

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3846402A (en) * 1971-05-06 1974-11-05 Max Planck Gesellschaft Thiophosphate analogues of the nucleoside diphosphates and triphosphates and a method for the preparation thereof
GB1433507A (en) * 1972-05-15 1976-04-28 Takeda Chemical Industries Ltd Pharmaceutically active 2-substituted adenosine-3,5-cyclic monophosphates
DE2331223A1 (de) * 1972-06-19 1974-01-17 Kohjin Co S-substituierte-2-thioadenosine
US4266048A (en) * 1977-10-11 1981-05-05 The United States Of America As Represented By The Department Of Health, Education And Welfare Synthesis of analogs of 3'-phosphoadenosine 5'-phosphosulfate (PAPS)
US4828979A (en) * 1984-11-08 1989-05-09 Life Technologies, Inc. Nucleotide analogs for nucleic acid labeling and detection
US4719295A (en) * 1985-12-31 1988-01-12 Warner-Lambert Company Compound 2-iodo-2'-deoxyadenosine
WO1992017488A1 (en) * 1991-04-06 1992-10-15 Fisons Plc Atp analogues
WO1994018216A1 (en) * 1993-02-10 1994-08-18 Astra Pharmaceuticals Limited N-alkyl-2-substituted atp analogues
WO1995010287A1 (en) * 1993-10-15 1995-04-20 Wisconsin Alumni Research Foundation Substituted purine nucleoside analogs and method for treating endotoxin shock
WO1996029345A1 (en) * 1995-03-23 1996-09-26 The Trustees Of The University Of Pennsylvania Novel inotropic agents

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BOYER, J.L. ET AL.: "Identification of competitive antagonists of the P2Y1 receptor", MOL. PHARMACOL., vol. 50, 1996, pages 1323 - 9, XP000944991 *
BRENNAN, C.A. AND GUMPORT, R. I.: "T4 RNA ligase catalyzed synthesis of base analogue-containing oligodeoxyribonucleotides and a characterization of thermal stabilities", NUCLEIC ACIDS RES., vol. 13, 1985, pages 8665 - 84, XP000944971 *
FISCHER, B. ET AL.: "Identification of potent, selective P2Y-purinoreceptor antagonists: relationship or 2-thioether derivatives of adenosine 5'-triphosphate", J. MED. CHEM., vol. 36, 1993, pages 3937 - 46, XP002155543 *
See also references of WO9818430A3 *
VAN RHEE, A.M. ET AL.: "Novel competitive antagonists for P2 purinoreceptors", EUR. J. PHARMACOL. MOL. PHARMACOL. SECT., vol. 268, 1994, pages 1 - 7, XP000944973 *

Also Published As

Publication number Publication date
EP0929218A2 (de) 1999-07-21
WO1998018430A2 (en) 1998-05-07
WO1998018430A3 (en) 1998-06-18
JP2001504097A (ja) 2001-03-27
CA2241687A1 (en) 1998-05-07
AU5584698A (en) 1998-05-22

Similar Documents

Publication Publication Date Title
DE69734833D1 (de) Vitronektin rezeptor antagonisten
NO972016D0 (no) Indolyl-Y-reseptorantagonister
DE69812096D1 (de) Neuropeptid y rezeptorantagonisten
FI955223L (fi) Adheesioreseptoriantagonisteja
NO951613D0 (no) Ikke-peptidyl tachykinin reseptorantagonister
EP0986385A4 (de) Antagonisten des gonadorelins
DK1009732T3 (da) 1-Amino-alkylcyclohexan NMDA receptor antagonister
IS5706A (is) Adenosín A3 viðtakastillar
EP0885205A4 (de) Fibrinogen-rezeptor-antagonisten
ATE280157T1 (de) 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii
EP0810994A4 (de) Fibrinogen-rezeptor-antagonisten
EP0866705A4 (de) Fibrinogenrezeptorantagonisten
DK0741133T3 (da) Adhæsionsreceptorantagonister
ID24726A (id) Antagonis-antagonis reseptor trombin
FI960516L (fi) Substituoituja bifenyylisulfonamidiendoteliiniantagonisteja
NO950606D0 (no) Adhesjonsreseptor-antagonister
DK0906294T3 (da) Benzoxazinon-dopamin D4-receptor-antagonister
EP0929218A4 (de) R2y rezeptor antagonisten
ID24162A (id) Antagonis-antagonis reseptor vitronektin
BR9707733A (pt) Antagonistas de receptores muscarinicos oxa-e-tia-diazol
FI955351L (fi) Tarttumisreseptoriantagonistit
BR9507220A (pt) Antagonistas de receptores de endotelina
DE69616364D1 (de) Endothelinrezeptorantagonisten
EP0957908A4 (de) Antagonisten des fibrinogen rezeptors
DE69615850D1 (de) G-protein-gekoppelter rezeptor hnfd578

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19981019

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 01N 43/04 A, 7C 07H 1/00 B, 7C 07H 19/00 B, 7C 07H 19/04 B, 7C 07H 19/20 B, 7C 07H 19/10 B, 7A 61K 31/70 B

A4 Supplementary search report drawn up and despatched

Effective date: 20010330

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20010502